Literature DB >> 22553539

Effect of adenovirus-mediated brain derived neurotrophic factor in early retinal neuropathy of diabetes in rats.

Chao Wan1, Ning-Ning Liu, Li-Min Liu, Na Cai, Lei Chen.   

Abstract

AIM: To observe effect of adenovirus-mediated brain derived neurotrophic factor in early retinal neuropathy of diabetes in rats.
METHODS: Adult male Wistar rats, 9 weeks of age, were injected intraperitoneally with STZ to induce diabetes. Two weeks after the models were established, Ad.BDNF was administered into the vitreous cavities of rats. Four weeks after the models were set up, the rats were killed and the retina was removed for Western blotting and whole-mount immunohistochemistry for tyrosine hydroxylase (TH) to observe the changes of TH and dopaminergic amacrine cells in retina.
RESULTS: The protein levels of TH and the number of positive staining dopaminergic amacrine cells and the staining gray scale of experimental group without Ad.BDNF were lower statistically. But there was no statistically significant difference between the experimental group with Ad.BDNF and control group.
CONCLUSION: In the early stage of STZ diabetic, the administration of Ad.BDNF into the vitreous cavities can increase TH protein levels and the density of dopaminergic amacrine cells in the STZ rats' retina.

Entities:  

Keywords:  adenovirus; brain derived neurotrophic factor; diabetic retinopathy; tyrosine hydroxylase

Year:  2010        PMID: 22553539      PMCID: PMC3340778          DOI: 10.3980/j.issn.2222-3959.2010.02.12

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  14 in total

1.  Cell death in the inner nuclear layer of the retina is modulated by BDNF.

Authors:  Karen Cusato; Alejandra Bosco; Rafael Linden; Benjamin E Reese
Journal:  Brain Res Dev Brain Res       Date:  2002-12-15

Review 2.  Molecular determinants of retinal ganglion cell development, survival, and regeneration.

Authors:  Stefan Isenmann; Alexandra Kretz; Alessandro Cellerino
Journal:  Prog Retin Eye Res       Date:  2003-07       Impact factor: 21.198

3.  Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo.

Authors:  J T Erickson; T A Brosenitsch; D M Katz
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

4.  Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons.

Authors:  M Nakamura; A J Barber; D A Antonetti; K F LaNoue; K A Robinson; M G Buse; T W Gardner
Journal:  J Biol Chem       Date:  2001-09-17       Impact factor: 5.157

5.  Neuroprotective effects of brain-derived neurotrophic factor in eyes with NMDA-induced neuronal death.

Authors:  N Kido; H Tanihara; M Honjo; M Inatani; T Tatsuno; C Nakayama; Y Honda
Journal:  Brain Res       Date:  2000-11-24       Impact factor: 3.252

6.  Diabetes-induced dysfunction of the glutamate transporter in retinal Müller cells.

Authors:  Qing Li; Donald G Puro
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-09       Impact factor: 4.799

Review 7.  The possible role of retinal dopaminergic system in visual performance.

Authors:  R Brandies; S Yehuda
Journal:  Neurosci Biobehav Rev       Date:  2007-10-10       Impact factor: 8.989

8.  The dopaminergic amacrine cell.

Authors:  D M Dacey
Journal:  J Comp Neurol       Date:  1990-11-15       Impact factor: 3.215

9.  Time course profiling of the retinal transcriptome after optic nerve transection and optic nerve crush.

Authors:  Marta Agudo; Maria Cruz Pérez-Marín; Ulrika Lönngren; Paloma Sobrado; Ana Conesa; Isabel Cánovas; Manuel Salinas-Navarro; Jaime Miralles-Imperial; Finn Hallböök; Manuel Vidal-Sanz
Journal:  Mol Vis       Date:  2008-06-03       Impact factor: 2.367

10.  Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation.

Authors:  Esther Carrasco; Cristina Hernández; Inés de Torres; Jaume Farrés; Rafael Simó
Journal:  Mol Vis       Date:  2008-08-15       Impact factor: 2.367

View more
  4 in total

1.  Therapeutic potential of adenovirus-encoding brain-derived neurotrophic factor for spina bifida aperta by intra-amniotic delivery in a rat model.

Authors:  Wei Ma; Xiaowei Wei; Hui Gu; Dan Liu; Wenting Luo; Dong An; Yuzuo Bai; Zhengwei Yuan
Journal:  Gene Ther       Date:  2020-02-24       Impact factor: 5.250

Review 2.  Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.

Authors:  Igor Khalin; Renad Alyautdin; Ganna Kocherga; Muhamad Abu Bakar
Journal:  Int J Nanomedicine       Date:  2015-04-30

Review 3.  Relevance of Peptide Homeostasis in Metabolic Retinal Degenerative Disorders: Curative Potential in Genetically Modified Mice.

Authors:  Etelka Pöstyéni; Alma Ganczer; Andrea Kovács-Valasek; Robert Gabriel
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

4.  The proinflammatory cytokine high-mobility group box-1 mediates retinal neuropathy induced by diabetes.

Authors:  Ahmed M Abu El-Asrar; Mohammad Mairaj Siddiquei; Mohd Imtiaz Nawaz; Karel Geboes; Ghulam Mohammad
Journal:  Mediators Inflamm       Date:  2014-03-10       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.